Author:
Rosbach J.,Schulze A.,Pfeiffer N.,Mirshahi A.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Jurklies B, Jurklies C, Schmidt U et al (2001) Kristalline korneoretinale Dystrophie (Bietti) – Langzeitverlauf von einem Patienten von 30 Jahren und interindividuelle Variabilität klinischer und elktrophysiologischer Befunde von zwei Patienten. Klin Monatsbl Augenheilkd 218:562–569
2. Charbel Issa P, Groppe M, MacLaren RE (2012) Gene therapy for retinal dystrophies. Ophthalmologe 109(2):121–128
3. Lai TY, Chu KO, Chan KP et al (2010) Alterations in serum fatty acid concentrations and desaturase activities in bietti chrystalline dystrophy unaffected by CYP4V2 genotypes. Invest Ophthalmol Vis Sci 51:1092–1097
4. Lee KY, Koh AH, Aung T (2005) Characterization of bietti crystalline dystrophy patients with CYP4V2 mutations. Invest Ophthalmol Vis Sci 46:3182–3186
5. Mamatha G, Umashankar V, Kasinathan N et al (2011) Molecular screening of the CYP4V2 gene in Bietti crystalline dystrophy that is associated with choroidal neovascularization. Molecular Vision 17:1970–1977